PERRY MARK L
Insider CIK 1190270 · NVDA Director · MYOK Director · GBT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NVDA NVIDIA CORP | S Sale | 2024-04-02 | 2024-04-03 | 7,000 | $887.89 | $6.22M | 116,000 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2024-02-23 | 2024-02-27 | 15,000 | $796.45 | $11.95M | 123,000 | SEC↗ |
| NVDA NVIDIA CORP | A Award | 2023-06-23 | 2023-06-27 | 650 | — | $0 | 13,612 | SEC↗ |
| NVDA NVIDIA CORP | G Gift | 2023-05-26 | 2023-05-31 | 1,000 | — | $0 | 1,000 | SEC↗ |
| NVDA NVIDIA CORP | G Gift | 2023-05-26 | 2023-05-31 | 1,000 | — | $0 | 1,000 | SEC↗ |
| NVDA NVIDIA CORP | G Gift | 2023-05-26 | 2023-05-31 | 2,000 | — | $0 | 138,000 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2023-02-27 | 2023-02-28 | 6,800 | $235.31 | $1.60M | 153,200 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2023-02-27 | 2023-02-28 | 6,100 | $236.25 | $1.44M | 147,100 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2023-02-27 | 2023-02-28 | 5,700 | $237.36 | $1.35M | 141,400 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2023-02-27 | 2023-02-28 | 1,400 | $238.00 | $333.2K | 140,000 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 3,600 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 15,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 7,500 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 5,247 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 5,600 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer deriv | 2022-10-05 | 2022-10-06 | 5,600 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | D To issuer | 2022-10-05 | 2022-10-06 | 37,865 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-06-14 | 2022-06-16 | 3,600 | — | $0 | 3,600 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2022-06-14 | 2022-06-16 | 3,600 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2022-06-14 | 2022-06-16 | 5,600 | — | $0 | 5,600 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2022-06-14 | 2022-06-16 | 3,600 | — | $0 | 37,865 | SEC↗ |
| NVDA NVIDIA CORP | A Award | 2022-06-03 | 2022-06-07 | 1,438 | — | $0 | 12,962 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2022-03-18 | 2022-03-21 | 1,800 | $262.90 | $473.2K | 26,440 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2022-03-18 | 2022-03-21 | 100 | $265.49 | $26.5K | 11,524 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2022-03-18 | 2022-03-21 | 12,100 | $263.67 | $3.19M | 14,340 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2022-03-18 | 2022-03-21 | 2,716 | $264.92 | $719.5K | 11,624 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2021-06-17 | 2021-06-21 | 3,600 | — | $0 | 3,600 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2021-06-17 | 2021-06-21 | 3,037 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2021-06-17 | 2021-06-21 | 5,600 | — | $0 | 5,600 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2021-06-17 | 2021-06-21 | 3,037 | — | $0 | 34,265 | SEC↗ |
| NVDA NVIDIA CORP | A Award | 2021-06-04 | 2021-06-08 | 429 | — | $0 | 7,060 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2021-04-05 | 2021-04-06 | 4,704 | $556.46 | $2.62M | 8,031 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2021-04-05 | 2021-04-06 | 1,400 | $556.98 | $779.8K | 6,631 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 3,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 21,800 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 11,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 11,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 11,000 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | D To issuer deriv | 2020-11-17 | 2020-11-19 | 6,600 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | U Tender | 2020-11-17 | 2020-11-19 | 29,508 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | A Award deriv | 2020-06-18 | 2020-06-22 | 1,800 | — | $0 | 1,800 | SEC↗ |
| MYOK MyoKardia, Inc. | A Award deriv | 2020-06-18 | 2020-06-22 | 3,000 | — | $0 | 3,000 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-06-17 | 2020-06-19 | 4,800 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-06-17 | 2020-06-19 | 3,037 | — | $0 | 3,037 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2020-06-17 | 2020-06-19 | 5,247 | — | $0 | 5,247 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-06-17 | 2020-06-19 | 4,800 | — | $0 | 31,228 | SEC↗ |
| MYOK MyoKardia, Inc. | M Exercise deriv | 2020-06-13 | 2020-06-16 | 2,300 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | M Exercise deriv | 2020-06-13 | 2020-06-23 | 2,300 | — | $0 | 0 | SEC↗ |
| MYOK MyoKardia, Inc. | M Exercise | 2020-06-13 | 2020-06-16 | 2,300 | — | $0 | 27,708 | SEC↗ |
| MYOK MyoKardia, Inc. | M Exercise | 2020-06-13 | 2020-06-23 | 2,300 | — | $0 | 27,708 | SEC↗ |
| NVDA NVIDIA CORP | A Award | 2020-06-10 | 2020-06-12 | 712 | — | $0 | 12,735 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-05-27 | 2020-05-29 | 2,200 | $331.31 | $728.9K | 17,929 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-05-27 | 2020-05-29 | 1,600 | $330.32 | $528.5K | 20,129 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-05-27 | 2020-05-29 | 1,300 | $329.28 | $428.1K | 21,729 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-05-27 | 2020-05-29 | 802 | $327.93 | $263.0K | 23,029 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-05-27 | 2020-05-29 | 400 | $326.51 | $130.6K | 23,831 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-05-27 | 2020-05-29 | 600 | $342.73 | $205.6K | 12,023 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-05-27 | 2020-05-29 | 300 | $341.54 | $102.5K | 12,623 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-05-27 | 2020-05-29 | 300 | $340.38 | $102.1K | 12,923 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-05-27 | 2020-05-29 | 600 | $339.16 | $203.5K | 13,223 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-05-27 | 2020-05-29 | 600 | $338.09 | $202.9K | 13,823 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-05-27 | 2020-05-29 | 800 | $336.97 | $269.6K | 14,423 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-05-27 | 2020-05-29 | 1,202 | $335.87 | $403.7K | 15,223 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-05-27 | 2020-05-29 | 404 | $333.45 | $134.7K | 16,425 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-05-27 | 2020-05-29 | 1,100 | $332.20 | $365.4K | 16,829 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-05-12 | 2020-05-13 | 8,600 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-05-12 | 2020-05-13 | 15,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-05-12 | 2020-05-13 | 15,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise deriv | 2020-05-12 | 2020-05-13 | 15,000 | — | $0 | 0 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-05-12 | 2020-05-13 | 15,000 | $28.45 | $426.8K | 80,028 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-05-12 | 2020-05-13 | 1,295 | $79.17 | $102.5K | 26,428 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-05-12 | 2020-05-13 | 34,698 | $78.65 | $2.73M | 27,723 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-05-12 | 2020-05-13 | 1,350 | $75.43 | $101.8K | 76,045 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-05-12 | 2020-05-13 | 8,600 | $20.00 | $172.0K | 50,028 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-05-12 | 2020-05-13 | 15,000 | $18.85 | $282.8K | 65,028 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-05-12 | 2020-05-13 | 2,633 | $74.01 | $194.9K | 77,395 | SEC↗ |
| GBT Global Blood Therapeutics, | M Exercise | 2020-05-12 | 2020-05-13 | 15,000 | $20.00 | $300.0K | 41,428 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-05-12 | 2020-05-13 | 13,024 | $77.71 | $1.01M | 62,421 | SEC↗ |
| GBT Global Blood Therapeutics, | S Sale | 2020-05-12 | 2020-05-13 | 600 | $76.28 | $45.8K | 75,445 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-02-18 | 2020-02-20 | 1,302 | $290.68 | $378.5K | 28,611 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-02-18 | 2020-02-20 | 400 | $294.19 | $117.7K | 26,395 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-02-18 | 2020-02-20 | 1,201 | $292.99 | $351.9K | 26,795 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-02-18 | 2020-02-20 | 2,013 | $289.68 | $583.1K | 29,913 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-02-18 | 2020-02-20 | 1,057 | $288.71 | $305.2K | 31,926 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-02-18 | 2020-02-20 | 615 | $291.76 | $179.4K | 27,996 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-02-18 | 2020-02-20 | 200 | $296.89 | $59.4K | 24,231 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-02-18 | 2020-02-20 | 1,459 | $296.36 | $432.4K | 24,431 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2020-02-18 | 2020-02-20 | 505 | $295.51 | $149.2K | 25,890 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-06-18 | 2019-06-20 | 7,500 | — | $0 | 7,500 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2019-06-18 | 2019-06-20 | 4,800 | — | $0 | 4,800 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2019-06-13 | 2019-06-17 | 6,600 | — | $0 | 6,600 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2019-06-13 | 2019-06-17 | 2,300 | — | $0 | 2,300 | SEC↗ |
| NVDA NVIDIA CORP | A Award | 2019-05-23 | 2019-05-28 | 1,258 | — | $0 | 32,983 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2018-06-20 | 2018-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2018-06-12 | 2018-06-14 | 11,000 | — | $0 | 11,000 | SEC↗ |
| NVDA NVIDIA CORP | A Award | 2018-05-17 | 2018-05-21 | 963 | — | $0 | 31,725 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2018-02-12 | 2018-02-13 | 17,307 | $227.93 | $3.94M | 30,762 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2017-08-14 | 2017-08-16 | 16,281 | $162.24 | $2.64M | 48,069 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2017-06-20 | 2017-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2017-06-14 | 2017-06-16 | 11,000 | — | $0 | 11,000 | SEC↗ |
| NVDA NVIDIA CORP | A Award | 2017-05-24 | 2017-05-26 | 2,058 | — | $0 | 64,350 | SEC↗ |
| NVDA NVIDIA CORP | G Gift | 2017-03-06 | 2017-05-26 | 10,000 | — | $0 | 40,000 | SEC↗ |
| NVDA NVIDIA CORP | M Exercise deriv | 2016-07-13 | 2016-07-15 | 35,000 | — | $0 | 0 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2016-07-13 | 2016-07-15 | 35,000 | $52.93 | $1.85M | 62,292 | SEC↗ |
| NVDA NVIDIA CORP | M Exercise | 2016-07-13 | 2016-07-15 | 35,000 | $17.78 | $622.3K | 97,292 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2016-06-16 | 2016-06-17 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2016-06-07 | 2016-06-09 | 11,000 | — | $0 | 11,000 | SEC↗ |
| NVDA NVIDIA CORP | A Award | 2016-05-19 | 2016-05-23 | 6,213 | — | $0 | 62,292 | SEC↗ |
| NVDA NVIDIA CORP | M Exercise deriv | 2015-11-12 | 2015-11-16 | 40,000 | — | $0 | 0 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2015-11-12 | 2015-11-16 | 40,000 | $30.49 | $1.22M | 56,079 | SEC↗ |
| NVDA NVIDIA CORP | M Exercise | 2015-11-12 | 2015-11-16 | 40,000 | $12.46 | $498.4K | 96,079 | SEC↗ |
| MYOK MyoKardia Inc | P Buy | 2015-11-03 | 2015-11-05 | 5,000 | $10.00 | $50.0K | 25,408 | SEC↗ |
| MYOK MyoKardia Inc | A Award deriv | 2015-10-28 | 2015-10-30 | 21,800 | — | $0 | 21,800 | SEC↗ |
| GBT Global Blood Therapeutics, | P Buy | 2015-08-17 | 2016-01-07 | 5,000 | $20.00 | $100.0K | 26,428 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2015-08-11 | 2015-08-13 | 8,600 | — | $0 | 8,600 | SEC↗ |
| GBT Global Blood Therapeutics, | A Award deriv | 2015-08-11 | 2015-08-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NVDA NVIDIA CORP | A Award | 2015-05-21 | 2015-05-26 | 10,283 | — | $0 | 56,079 | SEC↗ |
| NVDA NVIDIA CORP | M Exercise deriv | 2015-02-18 | 2015-02-18 | 48,000 | — | $0 | 0 | SEC↗ |
| NVDA NVIDIA CORP | S Sale | 2015-02-18 | 2015-02-18 | 48,000 | $22.20 | $1.07M | 45,796 | SEC↗ |
| NVDA NVIDIA CORP | M Exercise | 2015-02-18 | 2015-02-18 | 48,000 | $9.67 | $464.2K | 93,796 | SEC↗ |
| NVDA NVIDIA CORP | A Award | 2014-05-27 | 2014-05-28 | 12,208 | — | $0 | 45,796 | SEC↗ |
| NVDA NVIDIA CORP | A Award | 2013-05-16 | 2013-05-20 | 17,307 | — | $0 | 17,307 | SEC↗ |
| NVDA NVIDIA CORP | A Award | 2012-05-18 | 2012-05-22 | 16,281 | — | $0 | 66,281 | SEC↗ |